button bars forest bayes pooled summary circles
 
deaths (OS)

endometrial cancer endometrial cancer

versus placebo plus SoC
pembrolizumab plus SoC vs. placebo plus SoC 2 -
versus Standard of Care (SoC)
pembrolizumab plus lenvatinib vs. Standard of Care (SoC) 2 1.0better0.35.092 %

endometrial cancer - (neo)adjuvant (NA) endometrial cancer - (neo)adjuvant (NA)

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons